Viridian Therapeutics, Inc. (VRDN)
30.87
+0.39
(+1.28%)
USD |
NASDAQ |
Nov 13, 16:00
30.86
-0.01
(-0.03%)
After-Hours: 19:59
Viridian Therapeutics Price to Book Value : 7.261 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 7.261 |
| November 12, 2026 | 7.169 |
| November 11, 2026 | 7.35 |
| November 10, 2026 | 7.258 |
| November 09, 2026 | 7.101 |
| November 06, 2026 | 6.701 |
| November 05, 2026 | 6.715 |
| November 04, 2026 | 6.834 |
| November 03, 2026 | 5.915 |
| November 02, 2026 | 5.951 |
| October 30, 2026 | 5.802 |
| October 29, 2026 | 5.833 |
| October 28, 2026 | 5.708 |
| October 27, 2026 | 5.666 |
| October 26, 2026 | 5.490 |
| October 23, 2026 | 5.261 |
| October 22, 2026 | 5.367 |
| October 21, 2026 | 5.412 |
| October 20, 2026 | 5.276 |
| October 19, 2026 | 4.892 |
| October 16, 2026 | 4.476 |
| October 15, 2026 | 4.600 |
| October 14, 2026 | 4.323 |
| October 13, 2026 | 4.285 |
| October 12, 2026 | 4.304 |
| Date | Value |
|---|---|
| October 09, 2026 | 4.389 |
| October 08, 2026 | 4.314 |
| October 07, 2026 | 4.300 |
| October 06, 2026 | 4.285 |
| October 05, 2026 | 4.469 |
| October 02, 2026 | 4.563 |
| October 01, 2026 | 4.466 |
| September 30, 2026 | 4.843 |
| September 29, 2026 | 4.014 |
| September 28, 2026 | 4.129 |
| September 25, 2026 | 4.109 |
| September 24, 2026 | 4.148 |
| September 23, 2026 | 4.302 |
| September 22, 2026 | 4.441 |
| September 21, 2026 | 4.332 |
| September 18, 2026 | 4.416 |
| September 17, 2026 | 4.402 |
| September 16, 2026 | 4.505 |
| September 15, 2026 | 4.382 |
| September 14, 2026 | 4.457 |
| September 11, 2026 | 4.264 |
| September 10, 2026 | 4.475 |
| September 09, 2026 | 4.563 |
| September 08, 2026 | 4.651 |
| September 04, 2026 | 4.601 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Travere Therapeutics, Inc. | 214.57 |
| Arrowhead Pharmaceuticals, Inc. | 134.18 |
| Vertex Pharmaceuticals, Inc. | 6.531 |
| TG Therapeutics, Inc. | 17.04 |
| ACADIA Pharmaceuticals, Inc. | 2.335 |
Price to Book Value Related Metrics
| PS Ratio | 122.58 |
| PEG Ratio | -0.4055 |
| Price | 30.87 |
| Earnings Yield | -13.53% |
| Market Cap | 3.505B |
| PEGY Ratio | -0.4055 |